Results 111 to 120 of about 3,389 (131)
Imipenem/Relebactam Ex Vivo Clearance During Continuous Renal Replacement Therapy
(1) Purpose of this study: determination of adsorption and transmembrane clearances (CLTM) of imipenem and relebactam in ex vivo continuous hemofiltration (CH) and continuous hemodialysis (CHD) models.
Bruce Mueller +2 more
exaly +2 more sources
The imipenem-relebactam combination is in development as a potential treatment regimen for infections caused by Enterobacteriaceae possessing complex β-lactamase backgrounds.
Robert A Bonomo +2 more
exaly +2 more sources
BACKGROUND: Relebactam, previously known as MK-7655, is currently being tested in combination with imipenem as a class A and class C beta-lactamase inhibitor, including KPC from Klebsiella pneumoniae.
Reza Abniki, Amirhossein Tashakor
exaly +2 more sources
Some of the next articles are maybe not open access.

